Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Nutiani report reveals age-agnostic interest and proactive consumers in healthy ageing space 2024-06-27 06:00
The Future of Telehealth Relies on Seamless UC&C Monitoring 2024-06-26 21:30
HUADONG MEDICINE Announces Positive Phase I Results for Innovative Oral Small Molecule GLP-1 Receptor Agonist HDM1002 2024-06-26 21:05
TurtleTree Announces Strategic Partnership with Strive, a Sustainable Nutrition Company; Expands Consumer Product Offerings with LF+™ for Adult and Sports Nutrition 2024-06-26 21:01
Neurophet to present brain stimulation simulation study at OHBM 2024 2024-06-26 21:00
bioSeedin Expanded Global Licensing and Partnership Opportunities at 2024 BIO International Convention 2024-06-26 21:00
Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau 2024-06-26 20:56
CARING PHARMACY UNVEILS MOM & CUTIE PRODUCT LINE IN CELEBRATORY 30TH ANNIVERSARY EVENT 2024-06-26 20:49
Fufang E'jiao Syrup's Breakthrough Research on Cancer-Related Fatigue Receives "Special Excellence Award" at 2024 ASCO Annual Meeting 2024-06-26 18:42
Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea 2024-06-26 16:44
Apollo Cancer Centres Collaborates With Accuray to Launch India Sub- Continent's First Robotic Stereotactic Radiotherapy Program 2024-06-26 13:53
Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA 2024-06-26 12:36
Hyundai Bioscience succeeds in developing 'Multi-treatment for mosquito-borne viral infections' including Dengue Fever 2024-06-26 09:17
Yoshihiro Yoneda Appointed President of the International Human Frontier Science Program Organization 2024-06-26 08:00
AXA Introduces New TotalAssure Critical Illness Series 2024-06-25 22:21
ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation 2024-06-25 21:00
Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes 2024-06-25 20:22
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services 2024-06-25 20:00
Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression 2024-06-25 19:57
CLL Community Urges Hospital Authority to List Next-Generation BTK Inhibitor on Drug Formulary to Bring Hope and Improve Quality of Life for CLL Patients 2024-06-25 17:00
1 65 66 67 68 69 1618